• This record comes from PubMed

Hemophagocytic lymphohistiocytosis: Unraveling the role of SARS-CoV-2 infection

. 2026 Jan ; 13 (1) : 101764. [epub] 20250709

Status PubMed-not-MEDLINE Language English Country Netherlands Media electronic-ecollection

Document type Editorial

Links

PubMed 40978694
PubMed Central PMC12447879
DOI 10.1016/j.gendis.2025.101764
PII: S2352-3042(25)00253-3
Knihovny.cz E-resources

See more in PubMed

Chinnici A., Beneforti L., Pegoraro F., et al. Approaching hemophagocytic lymphohistiocytosis. Front Immunol. 2023;14 PubMed PMC

Khan M., Agudile E.P., Adhikari J., et al. Hemophagocytic lymphohistiocytosis (HLH) in a post-COVID-19 infection: a case report. Blood. 2023;142(Supplement 1):5367.

Jeyakanthan T., Ladel L., Khandpur B., Tan W.Y., Nasir S.A. Coronavirus does it again: post-COVID-19 hemophagocytic lymphohistiocytosis (HLH) Cureus. 2023;15(2) PubMed PMC

Fadlallah M.M., Salman S.M., Fadlallah M.M., Rahal H. Hemophagocytic syndrome and COVID-19: a comprehensive review. Cureus. 2023;15(3) PubMed PMC

Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...